Anthracycline

Apr 28, 2020

Cardioprotective Drug Prevents Severe Cardiac Events in Children Undergoing Chemotherapy for Acute Myeloid Leukemia

Apr 28, 2020

Moleculin Approved to Accelerate European Clinical Trial

Feb 20, 2020

Moleculin Announces Positive Independent Report of No Cardiotoxicity in Annamycin Phase 1 To Date

Feb 03, 2020

Moleculin Announces Successful Completion of US Phase 1 AML Trial of Annamycin

Dec 19, 2019

Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models

Dec 04, 2019

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

Jul 18, 2019

Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort

Mar 18, 2019

Moleculin Announces Memorial Sloan Kettering Chief of Leukemia Joins Science Advisory Board

Mar 06, 2019

Real World Evidence on Use of Halaven® (eribulin mesylate) Injection Following CDK 4/6 Inhibitor to be Presented at 36th Annual Miami Breast Cancer Conference

Jul 31, 2017

Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support